{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:51:06Z","timestamp":1762458666848},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,10,24]],"date-time":"2008-10-24T00:00:00Z","timestamp":1224806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s11307-008-0148-1","type":"journal-article","created":{"date-parts":[[2008,10,23]],"date-time":"2008-10-23T19:52:00Z","timestamp":1224791520000},"page":"79-87","source":"Crossref","is-referenced-by-count":11,"title":["Imaging and Pharmacokinetics of 64Cu-DOTA-HB22.7 Administered by Intravenous, Intraperitoneal, or Subcutaneous Injection to Mice Bearing Non-Hodgkin\u2019s Lymphoma Xenografts"],"prefix":"10.1007","volume":"11","author":[{"given":"Shiloh M.","family":"Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Kukis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig K.","family":"Abbey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayes","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie L.","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Tuscano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,24]]},"reference":[{"key":"148_CR1","unstructured":"Schumer ST, Joyce RM (2003) Radioimmunotherapy for Non-Hodgkin\u2019s Lymphoma. Progress in Oncology 46\u201372"},{"key":"148_CR2","doi-asserted-by":"crossref","unstructured":"Lindley C (1991) The lymphomas: Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphomas. Am Pharm NS31 46\u201351","DOI":"10.1016\/S0160-3450(16)33731-X"},{"key":"148_CR3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.semnuclmed.2005.02.006","volume":"35","author":"GL DeNardo","year":"2005","unstructured":"DeNardo GL (2005) Treatment of non-Hodgkin\u2019s lymphoma (NHL) with radiolabeled antibodies (mAbs). Semin Nucl Med 35:202\u2013211","journal-title":"Semin Nucl Med"},{"key":"148_CR4","first-page":"297","volume":"19","author":"GL DeNardo","year":"2001","unstructured":"DeNardo GL, O'Donnell RT, DeNardo SJ (2001) Radiolabeled anti-lymphoma antibodies. Cancer Chemother Biol Response Modif 19:297\u2013308","journal-title":"Cancer Chemother Biol Response Modif"},{"key":"148_CR5","first-page":"878","volume":"55","author":"DL Kukis","year":"1995","unstructured":"Kukis DL, DeNardo GL, DeNardo SJ et al (1995) Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates. Cancer Res 55:878\u2013884","journal-title":"Cancer Res"},{"key":"148_CR6","first-page":"1507","volume":"43","author":"ME Juweid","year":"2002","unstructured":"Juweid ME (2002) Radioimmunotherapy of B-cell non-Hodgkin\u2019s lymphoma: from clinical trials to clinical practice. J Nucl Med 43:1507\u20131529","journal-title":"J Nucl Med"},{"key":"148_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.soncn.2004.02.008","volume":"20","author":"MB Riley","year":"2004","unstructured":"Riley MB, Gordon LI (2004) Efficacy and safety of radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin). Semin Oncol Nurs 20:8\u201313","journal-title":"Semin Oncol Nurs"},{"key":"148_CR8","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3171\/jns.2004.100.2.0320","volume":"100","author":"GO Hjortland","year":"2004","unstructured":"Hjortland GO, Garman-Vik SS, Juell S (2004) Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme. J Neurosurg 100:320\u2013327","journal-title":"J Neurosurg"},{"key":"148_CR9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1100\/tsw.2006.162","volume":"6","author":"K Kawakami","year":"2006","unstructured":"Kawakami K, Nakajima O, Morishita R, Nagai R (2006) Targeted anticancer immunotoxins and cytotoxic agents with direct killing moieties. Scientific World Journal 6:781\u2013790","journal-title":"Scientific World Journal"},{"key":"148_CR10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.immunol.15.1.481","volume":"15","author":"TF Tedder","year":"1997","unstructured":"Tedder TF, Tuscano J, Sato S, Kehrl JH (1997) CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling. Annu Rev Immunol 15:481\u2013504","journal-title":"Annu Rev Immunol"},{"key":"148_CR11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/smim.1998.0121","volume":"10","author":"S Sato","year":"1998","unstructured":"Sato S, Tuscano JM, Inaoki M, Tedder TF (1998) CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor. Semin Immunol 10:287\u2013297","journal-title":"Semin Immunol"},{"key":"148_CR12","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V94.4.1382","volume":"94","author":"JM Tuscano","year":"1999","unstructured":"Tuscano JM, Riva A, Toscano SN, Tedder TF, Kehrl JH (1999) CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK\/SAPK signaling cascade. Blood 94:1382\u20131392","journal-title":"Blood"},{"key":"148_CR13","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1182\/blood-2002-08-2629","volume":"101","author":"JM Tuscano","year":"2003","unstructured":"Tuscano JM, O'Donnell RT, Miers LA et al (2003) Anti-CD22 ligand-blocking antibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA-peptide-Lym-1 in lymphoma xenografts. Blood 101:3641\u20133647","journal-title":"Blood"},{"key":"148_CR14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10555-005-6195-z","volume":"24","author":"MJ Koppe","year":"2005","unstructured":"Koppe MJ, Postema EJ, Aarts F, Oyen WJ, Bleichrodt RP, Boerman OC (2005) Antibody-guided radiation therapy of cancer. Cancer Metastasis Rev 24:539\u2013567","journal-title":"Cancer Metastasis Rev"},{"key":"148_CR15","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s002590100570","volume":"28","author":"EJ Postema","year":"2001","unstructured":"Postema EJ, Boerman OC, Oyen WJ, Raemaekers JM, Corstens FH (2001) Radioimmunotherapy of B-cell non-Hodgkin\u2019s lymphoma. Eur J Nucl Med 28:1725\u20131735","journal-title":"Eur J Nucl Med"},{"key":"148_CR16","first-page":"44","volume":"1","author":"LF O'Grady","year":"1986","unstructured":"O'Grady LF, DeNardo G, DeNardo S (1986) Radiolabelled monoclonal antibodies for the detection of cancer. Am J Physiol Imaging 1:44\u201353","journal-title":"Am J Physiol Imaging"},{"key":"148_CR17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3121\/cmr.3.3.157","volume":"3","author":"AV Rao","year":"2005","unstructured":"Rao AV, Akabani G, Rizzieri DA (2005) Radioimmunotherapy for Non-Hodgkin\u2019s Lymphoma. Clin Med Res 3:157\u2013165","journal-title":"Clin Med Res"},{"key":"148_CR18","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.jinorgbio.2004.06.009","volume":"98","author":"SV Smith","year":"2004","unstructured":"Smith SV (2004) Molecular imaging with copper-64. J Inorg Biochem 98:1874\u20131901","journal-title":"J Inorg Biochem"},{"key":"148_CR19","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.97.16.9226","volume":"97","author":"ME Phelps","year":"2000","unstructured":"Phelps ME (2000) Inaugural article: positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci USA 97:9226\u20139233","journal-title":"Proc Natl Acad Sci USA"},{"key":"148_CR20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/jcb.10616","volume":"90","author":"P Winnard Jr.","year":"2003","unstructured":"Winnard P Jr., Raman V (2003) Real time non-invasive imaging of receptor-ligand interactions in vivo. J Cell Biochem 90:454\u2013463","journal-title":"J Cell Biochem"},{"key":"148_CR21","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-02-0593","volume":"104","author":"G Hale","year":"2004","unstructured":"Hale G, Rebello P, Brettman LR et al (2004) Blood concentrations of alemtuzumab and antiglobin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration. Blood 104:948\u2013955","journal-title":"Blood"},{"key":"148_CR22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0003-2697(84)90517-7","volume":"142","author":"CF Meares","year":"1984","unstructured":"Meares CF, McCall MJ, Reardan DT, Goodwin DA, Diamanti CI, McTigue M (1984) Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions. Anal Biochem 142:68\u201378","journal-title":"Anal Biochem"},{"key":"148_CR23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0969-8051(96)00157-6","volume":"24","author":"DW McCarthy","year":"1997","unstructured":"McCarthy DW, Shefer RE, Klinkowstein RE et al (1997) Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl Med Biol 24:35\u201343","journal-title":"Nucl Med Biol"},{"key":"148_CR24","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1088\/0031-9155\/48\/11\/303","volume":"48","author":"YC Tai","year":"2003","unstructured":"Tai YC, Chatziioannou AF, Yang Y et al (2003) MicroPET II: design, development and initial performance of an improved microPET scanner for small-animal imaging. Phys Med Biol 48:1519\u20131537","journal-title":"Phys Med Biol"},{"key":"148_CR25","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1088\/0031-9155\/46\/11\/310","volume":"46","author":"A Chatziioannou","year":"2001","unstructured":"Chatziioannou A, Tai YC, Doshi N, Cherry SR (2001) Detector development for microPET II: a 1 microl resolution PET scanner for small animal imaging. Phys Med Biol 46:2899\u20132910","journal-title":"Phys Med Biol"},{"key":"148_CR26","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1088\/0031-9155\/43\/4\/027","volume":"43","author":"J Qi","year":"1998","unstructured":"Qi J, Leahy RM, Cherry SR, Chatziioannou A, Farquhar TH (1998) High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner. Phys Med Biol 43:1001\u20131013","journal-title":"Phys Med Biol"},{"key":"148_CR27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1109\/42.870260","volume":"19","author":"A Chatziioannou","year":"2000","unstructured":"Chatziioannou A, Qi J, Moore A et al (2000) Comparison of 3-D maximum a posteriori and filtered backprojection algorithms for high-resolution animal imaging with microPET. IEEE Trans Med Imaging 19:507\u2013512","journal-title":"IEEE Trans Med Imaging"},{"key":"148_CR28","doi-asserted-by":"crossref","first-page":"11438","DOI":"10.1073\/pnas.0404396101","volume":"101","author":"CK Abbey","year":"2004","unstructured":"Abbey CK, Borowsky AD, McGoldrick ET et al (2004) In vivo positron-emission tomography imaging of progression and transformation in a mouse model of mammary neoplasia. Proc Natl Acad Sci USA 101:11438\u201311443","journal-title":"Proc Natl Acad Sci USA"},{"key":"148_CR29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1109\/42.768839","volume":"18","author":"J Qi","year":"1999","unstructured":"Qi J, Leahy RM (1999) A theoretical study of the contrast recovery and variance of MAP reconstructions from PET data. IEEE Trans Med Imaging 18:293\u2013305","journal-title":"IEEE Trans Med Imaging"},{"key":"148_CR30","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1148\/rg.255045122","volume":"25","author":"C Love","year":"2005","unstructured":"Love C, Tomas MB, Tronco GG, Palestro CJ (2005) FDG PET of infection and inflammation. Radiographics 25:1357\u20131368","journal-title":"Radiographics"},{"key":"148_CR31","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s00330-005-0088-y","volume":"16","author":"SJ Rosenbaum","year":"2006","unstructured":"Rosenbaum SJ, Lind T, Antoch G, Bockisch A (2006) False-positive FDG PET uptake\u2014the role of PET\/CT. Eur Radiol 16:1054\u20131065","journal-title":"Eur Radiol"},{"key":"148_CR32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.rlu.0000222675.10765.14","volume":"31","author":"HA Jacene","year":"2006","unstructured":"Jacene HA, Stearns V, Wahl RL (2006) Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET\/CT. Clin Nucl Med 31:379\u2013381","journal-title":"Clin Nucl Med"},{"key":"148_CR33","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1084\/jem.181.4.1581","volume":"181","author":"P Engel","year":"1995","unstructured":"Engel P, Wagner N, Miller AS, Tedder TF (1995) Identification of the ligand binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand. J Exp Med 181:1581\u20131586","journal-title":"J Exp Med"},{"key":"148_CR34","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2141.1994.tb05109.x","volume":"88","author":"A Eischen","year":"1994","unstructured":"Eischen A, Doclos B, Schmitt-Goguel M et al (1994) Human resident peritoneal macrophages: phenotype and biology. Br J Haematol 88:712\u2013722","journal-title":"Br J Haematol"},{"key":"148_CR35","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1182\/blood.V28.3.455.455","volume":"28","author":"DM Whitelaw","year":"1966","unstructured":"Whitelaw DM (1966) The intravascular lifespan of monocytes. Blood 28:455\u2013464","journal-title":"Blood"},{"key":"148_CR36","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1074\/jbc.272.11.6927","volume":"272","author":"B Garner","year":"1997","unstructured":"Garner B, van Reyk D, Dean RT, Jessup W (1997) Direct copper reduction by macrophagesIts role in low density lipoprotein oxidation. J Biol Chem 272:6927\u20136935","journal-title":"J Biol Chem"},{"key":"148_CR37","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI117127","volume":"93","author":"E Ehrenwald","year":"1994","unstructured":"Ehrenwald E, Chisolm GM, Fox PL (1994) Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest 93:1493\u20131501","journal-title":"J Clin Invest"},{"key":"148_CR38","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1172\/JCI118491","volume":"97","author":"E Ehrenwald","year":"1996","unstructured":"Ehrenwald E, Fox PL (1996) Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells. J Clin Invest 97:884\u2013890","journal-title":"J Clin Invest"},{"key":"148_CR39","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1073\/pnas.0306622101","volume":"101","author":"J Chung","year":"2004","unstructured":"Chung J, Haile DJ, Wessling-Resnick M (2004) Copper-induced ferroportin-1 expression in J774 macrophages is associated with increased iron efflux. Proc Natl Acad Sci USA 101:2700\u20132705","journal-title":"Proc Natl Acad Sci USA"},{"key":"148_CR40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-4173(86)90005-4","volume":"853","author":"F Rossi","year":"1986","unstructured":"Rossi F (1986) The O2 \u2212-forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. Biochim Biophys Acta 853:65\u201389","journal-title":"Biochim Biophys Acta"},{"key":"148_CR41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1172\/JCI107236","volume":"52","author":"BM Babior","year":"1973","unstructured":"Babior BM, Kipnes RS, Curnutte JT (1973) Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52:741\u2013744","journal-title":"J Clin Invest"},{"key":"148_CR42","doi-asserted-by":"crossref","first-page":"C118","DOI":"10.1152\/ajpcell.2000.278.1.C118","volume":"278","author":"P Pietarinen-Runtti","year":"2000","unstructured":"Pietarinen-Runtti P, Lakari E, Raivio KO, Kinnula VL (2000) Expression of antioxidant enzymes in human inflammatory cells. Am J Physiol Cell Physiol 278:C118\u2013C125","journal-title":"Am J Physiol Cell Physiol"},{"key":"148_CR43","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1158\/1078-0432.CCR-05-0227","volume":"11","author":"J Grunberg","year":"2005","unstructured":"Grunberg J, Novak-Hofer I, Honer M et al (2005) In-vivo evaluation of 177Lu- and 67\/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM positive tumors. Clin Cancer Res 11:5112\u20135120","journal-title":"Clin Cancer Res"},{"key":"148_CR44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/10849780152752083","volume":"16","author":"MR Lewis","year":"2001","unstructured":"Lewis MR, Boswell CA, Laforest R et al (2001) Conjugation of monoclonal antibodies with TETA using activated esters: biological comparison of 64Cu-TETA-1A3 with 64Cu-BAT-2IT-1A3. Cancer Biother Radiopharm 16:483\u2013494","journal-title":"Cancer Biother Radiopharm"},{"key":"148_CR45","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1007\/s00259-007-0503-5","volume":"34","author":"W Cai","year":"2007","unstructured":"Cai W, Ebrahimnejad A, Chen K et al (2007) Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice. Eur J Nucl Med Mol Imaging 34:2024\u20132036","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"148_CR46","first-page":"777","volume":"4","author":"GL DeNardo","year":"1991","unstructured":"DeNardo GL, DeNardo SJ, Meares CF et al (1991) Pharmacokinetics of copper-67 conjugated Lym-1, a potential therapeutic radioimmunoconjugate, in mice and in patients with lymphoma. Antibody Immunoconj Radiopharm 4:777\u2013785","journal-title":"Antibody Immunoconj Radiopharm"},{"key":"148_CR47","first-page":"217","volume":"29","author":"SV Deshpande","year":"1988","unstructured":"Deshpande SV, DeNardo SJ, Meares CF et al (1988) Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in Raji tumored mice. J Nucl Med 29:217\u2013225","journal-title":"J Nucl Med"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-008-0148-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-008-0148-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-008-0148-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:22:41Z","timestamp":1589034161000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-008-0148-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,24]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["148"],"URL":"https:\/\/doi.org\/10.1007\/s11307-008-0148-1","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,24]]}}}